Literature DB >> 33871191

Dermoscopic monitoring of erythroplasia of Queyrat treated with photodynamic therapy.

Minzhi Wu1, Liu Yang2, Jingjing Li1, Liang Zhao3.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33871191     DOI： 10.25259/IJDVL_89_20

Source DB:  PubMed          Journal:  Indian J Dermatol Venereol Leprol        ISSN： 0378-6323            Impact factor:   2.545


× No keyword cloud information.
  5 in total

Review 1.  Dermoscopy in the diagnosis and management of basal cell carcinoma.

Authors:  Aimilios Lallas; Zoe Apalla; Dimitrios Ioannides; Giuseppe Argenziano; Fabio Castagnetti; Elvira Moscarella; Caterina Longo; Tamara Palmieri; Dafne Ramundo; Iris Zalaudek
Journal:  Future Oncol       Date:  2015-10-09       Impact factor: 3.404

2.  Methyl-aminolevulinate photodynamic therapy for the treatment of erythroplasia of Queyrat in 23 patients.

Authors:  Dario Fai; Ivana Romano; Nicoletta Cassano; Gino A Vena
Journal:  J Dermatolog Treat       Date:  2011-09-04       Impact factor: 3.359

3.  Dermatoscopic findings of penile intraepithelial neoplasia: Bowenoid papulosis, Bowen disease and erythroplasia of Queyrat.

Authors:  Su-Lin Chan; Richard Edward Watchorn; Evangelia Panagou; Evdoxia Panou; Eugene Lh Ong; Kara Heelan; Aiman Haider; Alex Freeman; Christopher Barry Bunker
Journal:  Australas J Dermatol       Date:  2018-12-25       Impact factor: 2.875

4.  Accuracy of dermoscopy in distinguishing erythroplasia of Queyrat from common forms of chronic balanitis: results from a multicentric observational study.

Authors:  E Errichetti; A Lallas; A Di Stefani; Z Apalla; A Kyrgidis; F Lacarrubba; G Micali; A Galvan; S Piaserico; G Stinco
Journal:  J Eur Acad Dermatol Venereol       Date:  2018-12-11       Impact factor: 6.166

5.  Methylaminolaevulinic acid photodynamic therapy in the treatment of erythroplasia of Queyrat.

Authors:  Laurence Feldmeyer; Valérie Krausz-Enderlin; Bettina Töndury; Jürg Hafner; Lars E French; Günther F L Hofbauer
Journal:  Dermatology       Date:  2011-08-18       Impact factor: 5.366
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.